Skip to main content
. 2018 Oct 30;10(12):891–897. doi: 10.14740/jocmr3592w

Table 2. Symptoms and Extrapulmonary Involvement of Patients With MPP.

Symptom(s) Survivors
N = 187 (%)
Non-survivors
N = 16 (%)
P value
Chest pain 23 (12.3) 0 0.23
Dyspnea 126 (67.3) 8 (50) 0.17
Cough 133 (71.1) 5 (31.2) 0.003
Gastrointestinal 35 (18.7) 4 (25) 0.51
Headache 25 (13.3) 6 (37.5) 0.02
Weight loss 6 (3.2) 0 1.00
Fever 100 (53.4) 10 (62.5) 0.60
Musculoskeletal 2 (1) 3 (18.7) 0.003
Exacerbation of obstructive airway disease (OAD) 39 (20.8) 1 (6.2) 0.204
Patients given systemic steroids for OAD 39 (20.8) 1 (6.2) 0.204
Extrapulmonary involvement of MP
Renal 81 (43.3) 15 (93.8) 0.0001
Gastrointestinal 169 (90.4) 16 (100) 0.0001
Cardiovascular 39 (20.8) 11 (68.8) 0.0001
Hematological 29 (15.5) 3 (18.8) 0.72
Musculoskeletal 106 (56.7) 16 (100) 0.0003
Pulmonary involvement 150 (80.2) 16 (100) 0.047